New study from University of California, Irvine and University of California, Santa Barbara researchers demonstrates improved retinal function and vascular integrity, supporting further investigation ...

This prospective randomized clinical trial was approved by the Miami Veterans Affairs Medical Center Institutional Review Board and was HIPAA compliant. The study was registered with ClinicaTrials.gov ...

TOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) approved expanded U.S.

TOKYO, Jan. 8, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the U.S. Food and Drug Administration (FDA) accepted the revised ...

Pakistan Institute of Medical Sciences (PIMS) said on Tuesday that Pakistan Tehreek-e-Insaf (PTI) founder Imran Khan received a fourth dose of an intravitreal injection as part of his eye ...

Restore Vision Inc., a clinical-stage biotechnology company advancing gene therapies for retinal disorders, today announced the interim clinical results from its ongoing Phase 1/2 first-in-human trial ...

Imran Khan, the founder of Pakistan Tehreek-e-Insaf (PTI), underwent his fourth intravitreal eye injection on Tuesday at Pakistan Institute of Medical Sciences (Pims) as part of his ongoing treatment.

PIMS says Imran Khan received a fourth intravitreal injection at the hospital after ophthalmologists found him clinically stable and OCT showed improvement. He was discharged the same day with ...

PTI founder was discharged following the procedure, says hospital spokesperson; Gohar reiterates call for Imran's treatment ...